The highly anticipated financial results for the third quarter of GeneDx Holdings Corp (WGS) are scheduled to be disclosed on Tuesday 29th October 2024. This important update will be made available before market open, providing investors and market participants with key information regarding the company's financial status.
According to predictions from financial analysts on Wall Street, the organization is expected to report an estimated per share $0.21 loss for the quarter. Furthermore, the company is anticipated to unveil a total revenue of $64.99 million during this period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $263.37 million for the full year. Moreover, they anticipate the earnings per share to reach loss of $0.78 during the fiscal year.
The per-share loss of $1.22 was highlighted in the company's earnings report for the same quarter of the prior year. This notable figure was achieved due to the company's impressive total revenue of $53.3 million recorded during that specific period.
In addition, The firm will review the third quarter financial results on 29th October 2024 at 08:30 AM eastern time, in a conference call with public.
GeneDx Holdings Corp (WGS) shares experienced a range of $58.32 to $61.35 on a day volume of 377.50 thousand shares. The stock closed Friday's regular trading session at $58.82, indicating a 0.46 percent decrease.